Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection?

Clinical Infectious Diseases

Volumn 37, Issue 1, 2003, Pages 65-72

  McConnell, Scott A ^a,b   Gubbins, Paul O ^a   Anaissie, Elias J ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Myeloma Institute for Research and Therapy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE; CYCLINE; MINOCYCLINE; NAFCILLIN; RIFAMPICIN; RIFAMYCIN; SULFADIAZINE SILVER;

ANAPHYLACTOID TOXICITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BLOOD FLOW; BLOOD SAMPLING; CANDIDA; CENTRAL VENOUS CATHETER; COAGULASE NEGATIVE STAPHYLOCOCCUS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DEVICE INFECTION; DISEASE SEVERITY; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; GENERAL CONDITION IMPROVEMENT; HUMAN; HYPOTHESIS; INFORMATION PROCESSING; LUPUS LIKE SYNDROME; MEDLINE; METHODOLOGY; MOLECULAR BIOLOGY; MORTALITY; NONHUMAN; PATIENT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; REVIEW; SIDE EFFECT; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DATABASES, FACTUAL; HUMANS; PROSTHESIS-RELATED INFECTIONS;

EID: 0038234864     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375227     Document Type: Review

References (67)

1. Pittet D. Nosocomial bloodstream infections. In: Wenzel RP, ed. Prevention and control of nosocomial infections. 3rd ed. Baltimore, MD: Lippincott, Williams & Wilkins, 1997:711-69.
2. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-601.
3. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002; 51:1-31.
4. Pearson ML. Guideline for prevention of intravascular device-related infections. I. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996; 24:262-77.
5. Pearson ML. Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996; 17:438-73.
6. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132:391-402.
7. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999; 281:261-7.
8. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999; 282:554-60.
9. Pemberton LB, Ross V, Cuddy P, Kremer H, Fessler T, McGurk E. No difference in catheter sepsis between standard and antiseptic central venous catheters: a prospective randomized trial. Arch Surg 1996; 131:986-9.
10. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997; 127:257-66.
11. Heard SO, Wagle M, Vijayakumar E, et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998; 158:81-7.
12. Bach A, Schmidt H, Bottiger B, et al. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J Antimicrob Chemother 1996; 37:315-22.
13. Ciresi DL, Albrecht RM, Volkers PA, Scholten DJ. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 1996; 62:641-6.
14. Tennenberg S, Lieser M, McCurdy B, et al. A prospective randomized trial of an antibiotic and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Arch Surg 1997; 132:1348-51.
15. Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest 1999; 115:1632-40.
16. George SJ, Vuddamalay P, Boscoe MJ. Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. Eur J Anaesthesiol 1997; 14:428-31.
17. Logghe C, Van Ossel C, D'Hoore W, Ezzedine H, Wauters G, Haxhe JJ. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect 1997; 37:145-56.
18. Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997; 127:267-74.
19. Hannan M, Juste RN, Umasanker S, et al. Antiseptic-bonded central venous catheters and bacterial colonization. Anaesthesia 1999; 54:868-72.
20. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24:584-602.
21. Kallman J, Kihlstrom E, Sjoberg L, Schollin J. Increase of staphylococci in neonatal septicaemia: a fourteen-year study. Acta Paediatr 1997; 86:533-8.
22. Toldos CM, Yague G, Ortiz G, Segovia M. Assessment of multiple coagulase-negative staphylococci isolated in blood cultures using pulsed-field gel electrophoresis. Eur J Clin Microbiol Infect Dis 1997; 16:581-6.
23. Jensen AG, Kirstein A, Jensen I, Scheibel J, Espersen F. A 6-month prospective study of hospital-acquired bacteremia in Copenhagen county. Scan J Infect Dis 1996; 28:601-8.
24. Engelhard D, Elishoov H, Strauss N, et al. Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter: a 5-year prospective study. Transplantation 1996; 61:430-4.
25. Herwaldt LA, Geiss M, Kao C, Pfaller MA. The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clin Infect Dis 1996; 22:14-20.
26. Arpi M, Renneberg J, Andersen HK, Nielsen B, Larsen SO. Bacteremia at a Danish university hospital during a twenty-five-year period (1968-1992). Scan J Infect Dis 1995; 27:245-51.
27. Peacock SJ, Bowler IC, Crook DW. Positive predictive value of blood cultures growing coagulase-negative staphylococci. Lancet 1995; 346:191-2.
28. Ringberg H, Thoren A, Bredberg A. Evaluation of coagulase-negative staphylococci in blood cultures: a prospective clinical and microbiological study. Scan J Infect Dis 1991; 23:315-23.
29. Roberts FJ, Geere IW, Coldman A. A three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis 1991; 13:34-46.
30. Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization: the true consequences of false-positive results. JAMA 1991; 265:365-9.
31. Fidalgo S, Vazquez F, Mendoza MC, Perez F, Mendez FJ. Bacteremia due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features. Reviews of Infectious Diseases 1990; 12:520-8.
32. Gatell JM, Trilla A, Latorre X, et al. Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis. Rev Infect Dis 1988; 10:203-10.
33. Kirchhoff LV, Sheagren JN. Epidemiology and clinical significance of blood cultures positive for coagulase-negative staphylococcus. Infect Control 1985; 6:479-86.
34. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168:400-7.
35. Segura M, Alvarez-Lerma F, Tellado JM, et al. A clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann Surg 1996; 223:363-9.
36. Weist K, Sperber A, Dietz E, Ruden H. Contamination of stopcocks mounted in administration sets for central venous catheters with replacement at 24 hours versus 72 hours: a prospective cohort study [abstract]. Infect Control Hosp Epidemiol 1997; 18:24.
37. Lang S, Livesley MA, Lambert PA, Elliott J, Elliott TS. The genomic diversity of coagulase-negative staphylococci associated with nosocomial infections. J Hosp Infect 1999; 43:187-93.
38. van Belkum A, Kluijtmans J, van Leeuwen W, et al. Monitoring persistence of coagulase-negative staphylococci in a hematology department using phenotypic and genotypic strategies. Infect Control Hosp Epidemiol 1996; 17:660-7.
39. Khatib R, Riederer KM, Clark JA, Khatib S, Briski LE, Wilson FM. Coagulase-negative staphylococci in multiple blood cultures: strain relatedness and determinants of same-strain bacteremia. J Clin Microbiol 1995; 33:816-20.
40. Kacica MA, Horgan MJ, Preston KE, Lepow M, Venezia RA. Relatedness of coagulase-negative staphylococci causing bacteremia in low-birthweight infants. Infect Control Hosp Epidemiol 1994; 15:658-62.
41. Archer GL. Molecular epidemiology of multiresistant Staphylococcus epidermidis. J Antimicrob Chemother 1988; 21:133-8.
42. Herwaldt LA, Hollis RJ, Boyken LD, Pfaller MA. Molecular epidemiology of coagulase-negative staphylococci isolated from immunocompromised patients. Infect Control Hosp Epidemiol 1992; 13:86-92.
43. Khabbaz RF, Cooksey RC, Saba G. The alimentary tract as a source of Staphylococcus epidermidis bacteremia in patients with cancer: clues from molecular epidemiology [abstract 1036]. In: Program and abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy (New York). Washington, DC: American Society for Microbiology, 1987:277.
44. Low DE, Schmidt BK, Kirpalani HM, et al. An endemic strain of Staphylococcus haemolyticus colonizing and causing bacteremia in neonatal intensive care unit patients. Pediatrics 1992; 89:696-700.
45. Lina B, Forey F, Troncy J, Greenland T, Fleurette J, Etienne J. Oral source of Staphylococcus epidermidis septicemia in a neutropenic patient. Eur J Clin Microbiol Infect Dis 1994; 13:773-5.
46. Betremieux P, Donnio PY, Pladys P. Use of ribotyping to investigate tracheal colonisation by Staphylococcus epidermidis as a source of bacteremia in ventilated newborns. Eur J Clin Microbiol Infect Dis 1995; 14:342-6.
47. Eastick K, Leeming JP, Bennett D, Millar MR. Reservoirs of coagulase negative staphylococci in preterm infants. Arch Dis Child Fetal Neonatal Ed 1996; 74:F99-104.
48. Matsuda J, Hirakata Y, Iori F, et al. Genetic relationship between blood and nonblood isolates from bacteremic patients determined by pulsed-field gel electrophoresis. J Clin Microbiol 1998; 36:3081-4.
49. Mueller-Premru M, Gubina M, Kaufmann ME, Primozic J, Cookson BD. Use of semi-quantitative and quantitative culture methods and typing for studying the epidemiology of central venous catheter-related infections in neonates on parenteral nutrition. J Med Microbiol 1999; 48:451-60.
50. Collignon PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994; 161:374-8.
51. Pittet D. Nosocomial bloodstream infections in the critically ill [reply]. JAMA 1994; 272:1820.
52. Bates DW, Lee TH. Rapid classification of positive blood cultures: prospective validation of a multivariate algorithm. JAMA 1992; 267:1962-6.
53. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999; 20:396-401.
54. Rello J. Impact of nosocomial infections on outcome: myths and evidence. Infect Control Hosp Epidemiol 1999; 20:392-4.
55. Vallés J, León C, Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multi-center study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin Infect Dis 1997; 24:387-95.
56. Pittet D, Li N, Woolson RF, Wenzel PP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997; 24:1068-78.
57. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160:976-81.
58. Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000; 162:1027-30.
59. Byers KE, Adal KA, Anglim AM, Farr BM. Case fatality rate for catheter-related bloodstream infections: a meta-analysis [abstract 43]. In: Program and abstracts of the 5th Annual Meeting of the Society of Healthcare Epidemiology of America (San Diego). Vol. 16(4). Mt. Royal, NJ: The Society of Healthcare Epidemiology of America, 1995:23.
60. Farr BM. Preventing vascular catheter-related infections: current controversies. Clin Infect Dis 2001; 33:1733-8.
61. Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous [correction of nervous] catheter. Anesthesiology 1997; 87:1242-4.
62. US Food and Drug Administration. FDA public health notice: potential hypersensitivity reactions to chlorhexidine-impregnated medical devices. 11 March 1998. Available at: http://www.fda.gov/cdrh/chlorhex.html. Accessed 19 June 2003.
63. Sturkenboom MC, Meier CR, Jick H, Stricker BH. Minocycline and lupuslike syndrome in acne patients. Arch Intern Med 1999; 159:493-7.
64. Masson C, Chevailler A, Pascaretti C, Legrand E, Bregeon C, Audran M. Minocycline related lupus. J Rheumatol 1996; 23:2160-1.
65. Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996; 173:418-24.
66. Sampath LA, Tambe SM, Modak SM. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 2001; 22:640-6.
67. Archer GL, Armstrong BC. Alteration of staphylococcal flora in cardiac surgery patients receiving antibiotic prophylaxis. J Infect Dis 1983; 147:642-9.